MetaCap

Zevra Therapeutics Insider Trades

NASDAQ: ZVRAHealth CareBiotechnology: Pharmaceutical PreparationsUSD

8.76-0.31 (-3.42%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

Last 12 months

Purchases
0 · $0
Sales
13 · $2.52M
Shares bought / sold
0 / 244.18K
Net activity
Net selling $2.5 million

Zevra Therapeutics insider activity

Over the last 12 months, Zevra Therapeutics insiders reported 28 transactions on SEC Form 4: 0 open-market purchases and 13 sales. Insiders bought $0 and sold $2.5 million worth of stock, for net insider selling of $2.5 million. The largest seller was McFarlane Neil F., with $1.2 million in reported sales.

The most recent filing shows McFarlane Neil F. (President and CEO) selling 20,000 shares at $11.25 on Oct 12, 2026. Insider sales are common for compensation, tax and diversification reasons, while open-market purchases are rarer; tracking both helps put ZVRA's ownership changes in context.

Summary generated from market data by MetaCap's automated system. Methodology

ZVRA insider transactions

Zevra Therapeutics insider transactions
DateInsiderTypeSharesValueFiling
Oct 12, 2026McFarlane Neil F.President and CEOSale20,000$224.95KForm 4
Oct 10, 2026McFarlane Neil F.President and CEOOption exercise50,000—Form 4
Aug 14, 2026Thompson RahsaanChief Legal & ComplianceSale42,666$474.77KForm 4
Aug 10, 2026Watton Corey MichaelDirectorSale12,300$138.38KForm 4
Aug 10, 2026Watton Corey MichaelDirectorOption exercise12,300$61.13KForm 4
Jun 22, 2026Thompson RahsaanChief Legal & ComplianceSale34,557$438.30KForm 4
Jun 21, 2026Thompson RahsaanChief Legal & ComplianceOption exercise66,667—Form 4
May 11, 2026Thompson RahsaanChief Legal & ComplianceSale1,794$20.27KForm 4
Mar 24, 2026Bode John BDirectorOption exercise39,200$191.69KForm 4
Mar 24, 2026Bode John BDirectorOption exercise39,200$194.82KForm 4
Feb 9, 2026McFarlane Neil F.President and CEOSale14,625$125.19KForm 4
Feb 7, 2026McFarlane Neil F.President and CEOOption exercise37,500—Form 4
Feb 3, 2026Sangiovanni Timothy J.SVP, Finance & Corp ControllerSale3,000$27.55KForm 4
Feb 3, 2026Schafer JoshuaCCOSale10,500$96.50KForm 4
Feb 2, 2026McFarlane Neil F.President and CEOSale91,000$853.43KForm 4
Jan 31, 2026McFarlane Neil F.President and CEOOption exercise233,334—Form 4
Jan 31, 2026Sangiovanni Timothy J.SVP, Finance & Corp ControllerOption exercise11,666—Form 4
Jan 31, 2026Schafer JoshuaCCOOption exercise35,334—Form 4
Jan 30, 2026Quartel Adrian WChief Medical OfficerSale4,533$40.04KForm 4
Jan 30, 2026Quartel Adrian WChief Medical OfficerOption exercise11,333—Form 4
Jan 30, 2026Thompson RahsaanChief Legal & ComplianceSale4,080$36.01KForm 4
Jan 30, 2026Thompson RahsaanChief Legal & ComplianceOption exercise11,333—Form 4
Jan 30, 2026Sangiovanni Timothy J.SVP, Finance & Corp ControllerSale1,750$15.44KForm 4
Jan 30, 2026Sangiovanni Timothy J.SVP, Finance & Corp ControllerOption exercise6,333—Form 4
Jan 30, 2026Schafer JoshuaCCOSale3,375$29.80KForm 4
Jan 30, 2026Schafer JoshuaCCOOption exercise11,333—Form 4
Dec 31, 2025Clifton R. LaDuaneFormer CFO & TreasurerTax withholding48,513$434.68KForm 4
Dec 31, 2025Clifton R. LaDuaneFormer CFO & TreasurerOption exercise140,667—Form 4
Oct 10, 2025McFarlane Neil F.President and CEOSale19,500$210.91KForm 4
Oct 10, 2025McFarlane Neil F.President and CEOOption exercise50,000—Form 4
Sep 12, 2025Shih AlvinDirectorBuy20,000$157.80KForm 4
Sep 12, 2025FAVORITO TAMARA ADirectorBuy3,175$24.72KForm 4
Aug 19, 2025Bode John BDirectorBuy5,000$45.83KForm 4
Jun 26, 2025Thompson RahsaanChief Legal & ComplianceSale24,000$221.00KForm 4
Jun 21, 2025Thompson RahsaanChief Legal & ComplianceOption exercise66,666—Form 4
Mar 28, 2025Watton Corey MichaelDirectorBuy300$2.35KForm 4
Mar 19, 2025Bode John BDirectorBuy10,000$79.62KForm 4
Feb 13, 2025Sangiovanni Timothy J.SVP, Finance & Corp ControllerSale3,000$23.59KForm 4

Transaction codes follow SEC Form 4: P = open-market purchase, S = open-market sale, A = grant or award, M = option exercise, F = shares withheld for taxes. About Form 4

Related